Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06336213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 1, 2025 to Dec 15, 2026
    • Study completion date: Dec 15, 2025 to Feb 15, 2027
    • Start date: Feb 19, 2024 to Jan 23, 2024
    • Site details revised
    v3
  2. Primary completion date: Nov 1, 2024 to Nov 1, 2025
    • Study completion date: Dec 15, 2024 to Dec 15, 2025
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.
Trial Details
NCT Number NCT06336213
Lead Sponsor Petrovsky National Research Centre of Surgery
Conditions
(from sponsor)		 Aortic Aneurysm and Dissection, Cardiac Valve Disease, Thoracic Aortic Aneurysm, Thoracic Aortic Dissection
Related terms Aortic Aneurysm, Aortic Aneurysm, Thoracic, Aortic Dissection, Dissection, Thoracic Aorta, Heart Valve Diseases
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov